Accretive Wealth Partners’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Accretive Wealth Partners’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Hold	7,984	–	–	0.05%	173
2026 Q1	$202K	Hold	7,984	–	–	0.06%	173
2025 Q4	$204K	Hold	7,984	–	–	0.06%	150
2025 Q3	$205K	Hold	7,984	–	–	0.06%	147
2025 Q2	$202K	Buy	+7,984	New	+$198K	0.07%	149

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Accretive Wealth Partners's IBDX Position: Q2 2026 in Review

Accretive Wealth Partners held its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) position steady in Q2 2026 at 7,984 shares worth $201K. The position accounts for 0.05% of the portfolio, ranked #173.

Accretive Wealth Partners first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $205K in Q3 2025. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

Accretive Wealth Partners held 7,984 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $201K as of Q2 2026.
Accretive Wealth Partners left its iShares iBonds Dec 2032 Term Corporate ETF share count unchanged in Q2 2026.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.05% of Accretive Wealth Partners's portfolio in Q2 2026, its #173 holding.
Accretive Wealth Partners first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
Accretive Wealth Partners's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $205K in Q3 2025.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Accretive Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.